Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trafficking protein particle complex subunit 10 (TRAPPC10) is a specific subunit of the transport protein particle (TRAPP) II complex, a conserved multisubunit tethering complex essential for vesicle-mediated trafficking in eukaryotic cells. TRAPPC10 is a transmembrane protein localized to the cis-Golgi network and functions primarily in late Golgi trafficking by acting as a membrane tether, facilitating vesicle docking and fusion events critical for ER-to-Golgi and intra-Golgi transport. It participates in the organization of the Golgi apparatus and is necessary for proper secretory pathway function. Multiple alternatively spliced mRNA variants exist, with possibly tissue-specific roles. Pathogenic variants in TRAPPC10 have been implicated in severe neurodevelopmental disorders, including microcephalic syndromes in humans and mice[1][2][3][4][5][6]. There are currently no characterized pharmacological inhibitors or drugs directly targeting TRAPPC10, and it is not a common direct therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trafficking protein particle complex subunit 10 (TRAPPC10).